Artificial intelligence is advancing rapidly in drug development, but it is facing a major threat from exaggerated marketing claims. Press releases often portray AI as a miracle product that can unlock the secrets of biology and cure diseases with ease. This hype is concerning to industry experts, with Daphne Koller from Insitro warning against unrealistic expectations. The reality is that AI can map molecules and predict their interactions on a computer screen, but reaching a cure is not as simple as it is made out to be in infomercials. The industry needs to manage expectations and focus on realistic outcomes.
Source link
Experts on separating hype from reality
